However, due to the insulin-sensitizing effects of DPP-4 inhibitors and the inherent risk of hypoglycemia associated with premixed insulin (6, 37), we hypothesize that the combination of vildagliptin and premixed insulin may lead to an increased likelihood of hypoglycemic episodes. This evidence concerns the gene INS and Hypoglycemia.